{
 "as_of": "2026-11-08",
 "cmr": "us-cm-kg/NASDAQ/IVA",
 "fence": "The page is the record's research on the issuer — no analyst, no rating, no view.",
 "markdown": "The page is the record's research on the issuer — no analyst, no rating, no view.\n\n# Inventiva S.A. (NASDAQ: IVA) — research page\n\nAs of 2026-11-08 · us-cm-kg · record version 1\n\n## Identity and listing\n\nThe issuer is Inventiva S.A., listed on NASDAQ under ticker IVA. Its ISIN is US46124U1079. Its LEI is not on the record, as there is no GLEIF record with the exact legal name in jurisdiction US-I0. Its security type is non-operating entity type (other), its segment is not on the record, its sector is 2834 Pharmaceutical Preparations, and its jurisdiction is France. The issuer is listed and not halted.\n\n## The disclosure read\n\nThe record holds 43 filings in the twelve months to 2026-11-08, across 30 filing days: 4 prospectus, 16 regulatory filing and 23 results. The median gap between filing days is 6 days. The latest filing is dated 2026-10-27 and is a regulatory filing, 12 days before the record date. The exchange median on NASDAQ is 6.0 days cadence, 52 filings and 5.0 days latency across 4,359 issuers. The sector median for 2834 Pharmaceutical Preparations is 6.0 days cadence, 63.0 filings and 4.0 days latency across 526 issuers.\n\n## Auditor\n\nThe auditor is not on the record, as there is no dei:AuditorName tag on the latest annual report cover, and foreign private issuers and older filings carry none. The auditor location is not on the record. The record holds no auditor changes.\n\n## Events and halts\n\nThe record holds no listing, delisting or name change lines. The domicile change is not on the record, as EDGAR states no dated change of state of incorporation on a filing line. The segment move is not on the record, as the exchanges' tier transfers are not EDGAR filings. The halt flag reads listed, not halted.\n\n## Orderability\n\nThe outcome is not determinable. The chapter's orderability section carries no client categories, so the outcome cannot name its client category. The rule version is acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1, and the chapter is as of 2026-11-04.\n\n## Coverage\n\nThe record finds 17 research houses named on the issuer's own investor-relations page: Barclays, Canaccord Genuity, Cantor Fitzgerald, Guggenheim, HC Wainwright, Jefferies, KBC, Leerink, LifeSci Capital, Piper Sandler, Portzamparc BNP Paribas, Stifel, TD Cowen, Truist, UBS, Van Lanschot Kempen and Wolfe Research.\n\n## Open research\n\nThe record holds no openly published research notes on the issuer. None was found.\n\n## Licensed\n\nLicensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.\n\n## As-of depth\n\nThe record holds sealed years 2021, 2022, 2023, 2024, 2025 and 2026 for the issuer. The market's earliest sealed date is 2021-01-04. The live record began on 2026-09-12.\n\n## Sources\n\n8 source pages are named on this page; every value above carries its own source page and read date in the numbers.\n\n- https://www.sec.gov/files/company_tickers_exchange.json (identity.exchange)\n- https://www.sec.gov/data-research/sec-markets-data/fails-deliver-data (identity.isin)\n- https://data.sec.gov/submissions/CIK0001756594.json (identity.jurisdiction)\n- https://mcp.us-cm-kg.ai/events/NASDAQ/IVA (the disclosure lines)\n- https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts (the halt flag)\n- https://mcp.us-cm-kg.ai/book/aio.json (the orderability chapter)\n- https://inventivapharma.com/investors/stocks/ (coverage)\n- https://mcp.us-cm-kg.ai/record/NASDAQ/IVA (the record)\n",
 "market": "US",
 "node": "us-cm-kg",
 "numbers": {
  "as_of_depth": {
   "issuer_years_sealed": [
    "2021",
    "2022",
    "2023",
    "2024",
    "2025",
    "2026"
   ],
   "live_record_began": "2026-09-12",
   "node_history_from": "2021-01-04",
   "node_years_sealed": [
    "2021",
    "2022",
    "2023",
    "2024",
    "2025",
    "2026"
   ],
   "record_version": 1,
   "sealed": true
  },
  "auditor": {
   "auditor": {
    "market": "US",
    "reason": "no dei:AuditorName tag on the latest annual report cover (foreign private issuers and older filings carry none)",
    "state": "not_on_record"
   },
   "auditor_firm_id": {
    "market": "US",
    "state": "not_on_record"
   },
   "auditor_location": {
    "market": "US",
    "state": "not_on_record"
   },
   "changes": []
  },
  "cmr": "us-cm-kg/NASDAQ/IVA",
  "coverage": {
   "count": 17,
   "houses": [
    {
     "analyst": "Ellie Merle",
     "house": "Barclays",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-11",
     "source": "https://inventivapharma.com/investors/stocks/",
     "state": "sourced"
    },
    {
     "analyst": "Edward Nash",
     "house": "Canaccord Genuity",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-11",
     "source": "https://inventivapharma.com/investors/stocks/",
     "state": "sourced"
    },
    {
     "analyst": "Prakhar Agrawal",
     "house": "Cantor Fitzgerald",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-11",
     "source": "https://inventivapharma.com/investors/stocks/",
     "state": "sourced"
    },
    {
     "analyst": "Seamus Fernandez",
     "house": "Guggenheim",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-11",
     "source": "https://inventivapharma.com/investors/stocks/",
     "state": "sourced"
    },
    {
     "analyst": "Ananda Ghosh",
     "house": "HC Wainwright",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-11",
     "source": "https://inventivapharma.com/investors/stocks/",
     "state": "sourced"
    },
    {
     "analyst": "Ben Jackson",
     "house": "Jefferies",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-11",
     "source": "https://inventivapharma.com/investors/stocks/",
     "state": "sourced"
    },
    {
     "analyst": "Mathijs Geerts Danau",
     "house": "KBC",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-11",
     "source": "https://inventivapharma.com/investors/stocks/",
     "state": "sourced"
    },
    {
     "analyst": "Thomas Smith",
     "house": "Leerink",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-11",
     "source": "https://inventivapharma.com/investors/stocks/",
     "state": "sourced"
    },
    {
     "analyst": "Rami Katkhuda",
     "house": "LifeSci Capital",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-11",
     "source": "https://inventivapharma.com/investors/stocks/",
     "state": "sourced"
    },
    {
     "analyst": "Yasmeen Rahimi",
     "house": "Piper Sandler",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-11",
     "source": "https://inventivapharma.com/investors/stocks/",
     "state": "sourced"
    },
    {
     "analyst": "Mohamed Kaabouni",
     "house": "Portzamparc BNP Paribas",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-11",
     "source": "https://inventivapharma.com/investors/stocks/",
     "state": "sourced"
    },
    {
     "analyst": "Annabel Samimy",
     "house": "Stifel",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-11",
     "source": "https://inventivapharma.com/investors/stocks/",
     "state": "sourced"
    },
    {
     "analyst": "Ritu Baral",
     "house": "TD Cowen",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-11",
     "source": "https://inventivapharma.com/investors/stocks/",
     "state": "sourced"
    },
    {
     "analyst": "Srikripa Devarakonda",
     "house": "Truist",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-11",
     "source": "https://inventivapharma.com/investors/stocks/",
     "state": "sourced"
    },
    {
     "analyst": "Mike Yee",
     "house": "UBS",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-11",
     "source": "https://inventivapharma.com/investors/stocks/",
     "state": "sourced"
    },
    {
     "analyst": "Sushila Hernandez",
     "house": "Van Lanschot Kempen",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-11",
     "source": "https://inventivapharma.com/investors/stocks/",
     "state": "sourced"
    },
    {
     "analyst": "Andy Chen",
     "house": "Wolfe Research",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-11",
     "source": "https://inventivapharma.com/investors/stocks/",
     "state": "sourced"
    }
   ],
   "pages_checked": [
    {
     "page": "https://inventivapharma.com/investors/stocks/",
     "result": "read: 17 of 34 named houses found on the page"
    }
   ],
   "read_by": "Perplexity sonar (search) · page read by this rail",
   "read_date": "2026-11-11",
   "since": "not stated on the page read",
   "state": "found"
  },
  "disclosure": {
   "against": {
    "exchange": {
     "issuers": 4359,
     "median_cadence_gap_days": 6,
     "median_filings": 52,
     "median_latency_days": 5,
     "name": "NASDAQ"
    },
    "sector": {
     "issuers": 526,
     "median_cadence_gap_days": 6,
     "median_filings": 63,
     "median_latency_days": 4,
     "name": "2834 Pharmaceutical Preparations"
    }
   },
   "by_type": {
    "prospectus": 4,
    "regulatory_filing": 16,
    "results": 23
   },
   "cadence_median_gap_days": 6,
   "filing_days": 30,
   "filings": 43,
   "latency_days": 12,
   "latest": [
    {
     "category": "SCHEDULE 13G/A",
     "date": "2026-10-27",
     "source": "https://www.sec.gov/Archives/edgar/data/1756594/000175728326000025/xslSCHEDULE_13G_X02/primary_doc.xml",
     "title": "SCHEDULE 13G/A",
     "type": "regulatory_filing"
    },
    {
     "category": "6-K",
     "date": "2026-10-06",
     "source": "https://www.sec.gov/Archives/edgar/data/1756594/000117184326006471/f6k_100626.htm",
     "title": "6-K — FORM 6-K",
     "type": "results"
    },
    {
     "category": "6-K",
     "date": "2026-09-28",
     "source": "https://www.sec.gov/Archives/edgar/data/1756594/000110465926111143/iva-20260630x6k.htm",
     "title": "6-K — FORM 6-K",
     "type": "results"
    },
    {
     "category": "6-K",
     "date": "2026-09-03",
     "source": "https://www.sec.gov/Archives/edgar/data/1756594/000117184326005860/f6k_090226.htm",
     "title": "6-K — FORM 6-K",
     "type": "results"
    },
    {
     "category": "6-K",
     "date": "2026-09-01",
     "source": "https://www.sec.gov/Archives/edgar/data/1756594/000117184326005810/f6k_083126.htm",
     "title": "6-K — FORM 6-K",
     "type": "results"
    }
   ],
   "latest_filing_date": "2026-10-27",
   "read": "the node's event lines (list_events_since), as get_filings serves them",
   "source": "https://mcp.us-cm-kg.ai/events/NASDAQ/IVA",
   "window": {
    "from": "2025-11-08",
    "to": "2026-11-08"
   }
  },
  "identity": {
   "exchange": {
    "read_by": "EDGAR company_tickers_exchange.json (SEC list of exchange-listed filers)",
    "read_date": "2026-11-08",
    "read_date_basis": "the record version as_of",
    "source": "https://www.sec.gov/files/company_tickers_exchange.json",
    "state": "sourced",
    "value": "NASDAQ"
   },
   "isin": {
    "read_by": "SEC Fails-to-Deliver data (CUSIP for the symbol) · ISIN = US + CUSIP + ISO 6166 check digit",
    "read_date": "2026-08-28",
    "read_date_basis": "last_seen",
    "source": "https://www.sec.gov/data-research/sec-markets-data/fails-deliver-data",
    "state": "sourced",
    "value": "US46124U1079"
   },
   "jurisdiction": {
    "read_by": "EDGAR submissions API (issuer header as filed) (stateOfIncorporation)",
    "read_date": "2026-11-08",
    "read_date_basis": "the record version as_of",
    "source": "https://data.sec.gov/submissions/CIK0001756594.json",
    "state": "sourced",
    "value": "France"
   },
   "lei": {
    "market": "US",
    "reason": "no GLEIF record with the exact legal name in jurisdiction US-I0",
    "state": "not_on_record"
   },
   "name": {
    "read_by": "EDGAR submissions API (issuer header as filed)",
    "read_date": "2026-11-08",
    "read_date_basis": "the record version as_of",
    "source": "https://data.sec.gov/submissions/CIK0001756594.json",
    "state": "sourced",
    "value": "Inventiva S.A."
   },
   "sector": {
    "read_by": "EDGAR submissions API (issuer header as filed) (SIC code as assigned by the SEC)",
    "read_date": "2026-11-08",
    "read_date_basis": "the record version as_of",
    "source": "https://data.sec.gov/submissions/CIK0001756594.json",
    "state": "sourced",
    "value": "2834 Pharmaceutical Preparations"
   },
   "security_type": {
    "read_by": "EDGAR submissions API (issuer header as filed)",
    "read_date": "2026-11-08",
    "read_date_basis": "the record version as_of",
    "source": "https://data.sec.gov/submissions/CIK0001756594.json",
    "state": "sourced",
    "value": "Non-operating entity type (other)"
   },
   "segment": {
    "market": "US",
    "state": "not_on_record"
   },
   "ticker": {
    "read_by": "EDGAR company_tickers_exchange.json (SEC list of exchange-listed filers)",
    "read_date": "2026-11-08",
    "read_date_basis": "the record version as_of",
    "source": "https://www.sec.gov/files/company_tickers_exchange.json",
    "state": "sourced",
    "value": "IVA"
   },
   "website": {
    "market": "US",
    "state": "not_on_record"
   }
  },
  "licensed": {
   "columns": [
    "licensor",
    "entitlement",
    "title",
    "date",
    "source"
   ],
   "rows": [],
   "rule": "A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded."
  },
  "lifecycle": {
   "delisting": [],
   "domicile_change": {
    "market": "US",
    "reason": "EDGAR states no dated change of state of incorporation on a filing line",
    "state": "not_on_record"
   },
   "listing": [],
   "name_change": [],
   "segment_move": {
    "market": "US",
    "reason": "the exchanges' tier transfers are not EDGAR filings",
    "state": "not_on_record"
   }
  },
  "market": "US",
  "node": "us-cm-kg",
  "numbers_hash": "sha256:9871125929b2dcf2b2dee96a998eaa2c6c8408b0bb0b91dd5fff95925768d985",
  "open_research": {
   "read_date": "2026-11-11",
   "rows": [],
   "state": "none_found"
  },
  "orderability": {
   "chapter_as_of": "2026-11-04",
   "client_categories": [],
   "determinable": false,
   "read": {
    "chapter": "https://mcp.us-cm-kg.ai/book/aio.json",
    "door": "https://mcp.us-cm-kg.ai/mcp",
    "tool": "get_orderability"
   },
   "reason": "the chapter's orderability section carries no client_categories: the outcome cannot name its client category",
   "rule_version": "acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1",
   "section": "us.aio.v8"
  },
  "record": {
   "as_of": "2026-11-08",
   "url": "https://mcp.us-cm-kg.ai/record/NASDAQ/IVA",
   "version": 1
  },
  "schema": "research-numbers v0.1 (USR-01, 2026-11-11)",
  "status": {
   "read_date": "2026-11-08",
   "source": "https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts",
   "value": "listed, not halted"
  }
 },
 "numbers_hash": "sha256:9871125929b2dcf2b2dee96a998eaa2c6c8408b0bb0b91dd5fff95925768d985",
 "path": "/us/NASDAQ/IVA",
 "schema": "research-page v0.1 (USR-02, 2026-11-11)",
 "sections": [
  {
   "id": "identity",
   "text": "The issuer is Inventiva S.A., listed on NASDAQ under ticker IVA. Its ISIN is US46124U1079. Its LEI is not on the record, as there is no GLEIF record with the exact legal name in jurisdiction US-I0. Its security type is non-operating entity type (other), its segment is not on the record, its sector is 2834 Pharmaceutical Preparations, and its jurisdiction is France. The issuer is listed and not halted.",
   "title": "Identity and listing"
  },
  {
   "id": "disclosure",
   "text": "The record holds 43 filings in the twelve months to 2026-11-08, across 30 filing days: 4 prospectus, 16 regulatory filing and 23 results. The median gap between filing days is 6 days. The latest filing is dated 2026-10-27 and is a regulatory filing, 12 days before the record date. The exchange median on NASDAQ is 6.0 days cadence, 52 filings and 5.0 days latency across 4,359 issuers. The sector median for 2834 Pharmaceutical Preparations is 6.0 days cadence, 63.0 filings and 4.0 days latency across 526 issuers.",
   "title": "The disclosure read"
  },
  {
   "id": "auditor",
   "text": "The auditor is not on the record, as there is no dei:AuditorName tag on the latest annual report cover, and foreign private issuers and older filings carry none. The auditor location is not on the record. The record holds no auditor changes.",
   "title": "Auditor"
  },
  {
   "id": "events",
   "text": "The record holds no listing, delisting or name change lines. The domicile change is not on the record, as EDGAR states no dated change of state of incorporation on a filing line. The segment move is not on the record, as the exchanges' tier transfers are not EDGAR filings. The halt flag reads listed, not halted.",
   "title": "Events and halts"
  },
  {
   "id": "orderability",
   "text": "The outcome is not determinable. The chapter's orderability section carries no client categories, so the outcome cannot name its client category. The rule version is acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1, and the chapter is as of 2026-11-04.",
   "title": "Orderability"
  },
  {
   "id": "coverage",
   "text": "The record finds 17 research houses named on the issuer's own investor-relations page: Barclays, Canaccord Genuity, Cantor Fitzgerald, Guggenheim, HC Wainwright, Jefferies, KBC, Leerink, LifeSci Capital, Piper Sandler, Portzamparc BNP Paribas, Stifel, TD Cowen, Truist, UBS, Van Lanschot Kempen and Wolfe Research.",
   "title": "Coverage"
  },
  {
   "id": "open_research",
   "text": "The record holds no openly published research notes on the issuer. None was found.",
   "title": "Open research"
  },
  {
   "id": "licensed",
   "text": "Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.",
   "title": "Licensed"
  },
  {
   "id": "depth",
   "text": "The record holds sealed years 2021, 2022, 2023, 2024, 2025 and 2026 for the issuer. The market's earliest sealed date is 2021-01-04. The live record began on 2026-09-12.",
   "title": "As-of depth"
  },
  {
   "id": "sources",
   "text": "8 source pages are named on this page; every value above carries its own source page and read date in the numbers.",
   "title": "Sources"
  }
 ],
 "sources": [
  {
   "for": "identity.exchange",
   "source": "https://www.sec.gov/files/company_tickers_exchange.json"
  },
  {
   "for": "identity.isin",
   "source": "https://www.sec.gov/data-research/sec-markets-data/fails-deliver-data"
  },
  {
   "for": "identity.jurisdiction",
   "source": "https://data.sec.gov/submissions/CIK0001756594.json"
  },
  {
   "for": "the disclosure lines",
   "source": "https://mcp.us-cm-kg.ai/events/NASDAQ/IVA"
  },
  {
   "for": "the halt flag",
   "source": "https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts"
  },
  {
   "for": "the orderability chapter",
   "source": "https://mcp.us-cm-kg.ai/book/aio.json"
  },
  {
   "for": "coverage",
   "source": "https://inventivapharma.com/investors/stocks/"
  },
  {
   "for": "the record",
   "source": "https://mcp.us-cm-kg.ai/record/NASDAQ/IVA"
  }
 ],
 "title": "Inventiva S.A. (IVA) — research page",
 "writer": {
  "by": "Claude through the platform account, Haiku class; one pass; checked against the numbers",
  "engine": "claude-haiku-5-5"
 }
}